Topotécane : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Topotécane : Questions médicales les plus fréquentes", "headline": "Topotécane : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Topotécane : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-09", "dateModified": "2026-08-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Topotécane" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Camptothécine", "url": "https://questionsmedicales.fr/mesh/D002166", "about": { "@type": "MedicalCondition", "name": "Camptothécine", "code": { "@type": "MedicalCode", "code": "D002166", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.132.151" } } }, "about": { "@type": "MedicalCondition", "name": "Topotécane", "alternateName": "Topotecan", "code": { "@type": "MedicalCode", "code": "D019772", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nadezhda S Dyrkheeva", "url": "https://questionsmedicales.fr/author/Nadezhda%20S%20Dyrkheeva", "affiliation": { "@type": "Organization", "name": "Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia." } }, { "@type": "Person", "name": "Olga I Lavrik", "url": "https://questionsmedicales.fr/author/Olga%20I%20Lavrik", "affiliation": { "@type": "Organization", "name": "Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia." } }, { "@type": "Person", "name": "O A Luzina", "url": "https://questionsmedicales.fr/author/O%20A%20Luzina", "affiliation": { "@type": "Organization", "name": "N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia." } }, { "@type": "Person", "name": "N F Salakhutdinov", "url": "https://questionsmedicales.fr/author/N%20F%20Salakhutdinov", "affiliation": { "@type": "Organization", "name": "N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia." } }, { "@type": "Person", "name": "Jasmine H Francis", "url": "https://questionsmedicales.fr/author/Jasmine%20H%20Francis", "affiliation": { "@type": "Organization", "name": "Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37806183", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.advms.2023.09.013" } }, { "@type": "ScholarlyArticle", "name": "Electrochemical Nanosensor for the Simultaneous Determination of Anticancer Drugs Epirubicin and Topotecan Using UiO-66-NH", "datePublished": "2024-05-04", "url": "https://questionsmedicales.fr/article/38785703", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/bios14050229" } }, { "@type": "ScholarlyArticle", "name": "Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37830151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3892/or.2023.8645" } }, { "@type": "ScholarlyArticle", "name": "Self-assembled ordered AuNRs-modified electrodes for simultaneous determination of dopamine and topotecan with improved data reproducibility.", "datePublished": "2024-05-28", "url": "https://questionsmedicales.fr/article/38806865", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00604-024-06441-x" } }, { "@type": "ScholarlyArticle", "name": "A simulated trial with reinforcement learning for the efficacy of Irinotecan and Ifosfamide versus Topotecan in relapsed, extensive stage small cell lung cancer.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39350046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12985-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Alcaloïdes", "item": "https://questionsmedicales.fr/mesh/D000470" }, { "@type": "ListItem", "position": 4, "name": "Camptothécine", "item": "https://questionsmedicales.fr/mesh/D002166" }, { "@type": "ListItem", "position": 5, "name": "Topotécane", "item": "https://questionsmedicales.fr/mesh/D019772" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Topotécane - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Topotécane", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-09-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Topotécane", "description": "Comment le topotécane est-il utilisé dans le diagnostic ?\nQuels tests précèdent l'administration de topotécane ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Topotécane", "description": "Quels sont les effets secondaires du topotécane ?\nLe topotécane cause-t-il des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Topotécane", "description": "Peut-on prévenir les effets secondaires du topotécane ?\nY a-t-il des mesures préventives avant le traitement ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Topotécane", "description": "Comment le topotécane est-il administré ?\nAvec quels autres traitements le topotécane est-il combiné ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Topotécane", "description": "Quelles complications peuvent survenir avec le topotécane ?\nComment gérer les complications du topotécane ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Topotécane", "description": "Qui est à risque d'effets indésirables du topotécane ?\nLe topotécane est-il sûr pour les personnes âgées ?", "url": "https://questionsmedicales.fr/mesh/D019772#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le topotécane est-il utilisé dans le diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le topotécane n'est pas utilisé pour le diagnostic, mais pour traiter des cancers diagnostiqués." } }, { "@type": "Question", "name": "Quels tests précèdent l'administration de topotécane ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et d'imagerie sont effectués pour évaluer la santé du patient et la progression du cancer." } }, { "@type": "Question", "name": "Quels sont les effets secondaires du topotécane ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, vomissements, fatigue, et baisse des globules blancs." } }, { "@type": "Question", "name": "Le topotécane cause-t-il des douleurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il peut provoquer des douleurs abdominales ou musculaires, mais ce n'est pas systématique." } }, { "@type": "Question", "name": "Peut-on prévenir les effets secondaires du topotécane ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antiémétiques peuvent être prescrits pour prévenir les nausées et vomissements." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives avant le traitement ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation médicale complète est nécessaire pour identifier les risques avant le traitement." } }, { "@type": "Question", "name": "Comment le topotécane est-il administré ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le topotécane est généralement administré par voie intraveineuse ou orale, selon le protocole." } }, { "@type": "Question", "name": "Avec quels autres traitements le topotécane est-il combiné ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il est souvent combiné avec d'autres chimiothérapies ou thérapies ciblées pour améliorer l'efficacité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le topotécane ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme l'infection, l'anémie et des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer les complications du topotécane ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut des soins de soutien, des transfusions sanguines et des antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Qui est à risque d'effets indésirables du topotécane ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les patients avec des antécédents de maladies hématologiques ou des allergies sont à risque accru." } }, { "@type": "Question", "name": "Le topotécane est-il sûr pour les personnes âgées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent être plus sensibles aux effets du topotécane et nécessitent une surveillance." } } ] } ] }